IL111909A0 - Combination preparations comprising a quinoxaline and a nucleoside - Google Patents

Combination preparations comprising a quinoxaline and a nucleoside

Info

Publication number
IL111909A0
IL111909A0 IL11190994A IL11190994A IL111909A0 IL 111909 A0 IL111909 A0 IL 111909A0 IL 11190994 A IL11190994 A IL 11190994A IL 11190994 A IL11190994 A IL 11190994A IL 111909 A0 IL111909 A0 IL 111909A0
Authority
IL
Israel
Prior art keywords
nucleoside
quinoxaline
combination preparations
formulae
substituents
Prior art date
Application number
IL11190994A
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL111909A0 publication Critical patent/IL111909A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A combination product containing at least one nucleoside and a compound of the formulae I and/or Ia, <IMAGE> or the physiologically tolerated salts thereof, where the symbols X and n, and the substituents R<1>-R<5>, have the stated meanings, display antiviral activity.
IL11190994A 1993-12-09 1994-12-07 Combination preparations comprising a quinoxaline and a nucleoside IL111909A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342024A DE4342024A1 (en) 1993-12-09 1993-12-09 Combination preparations containing a quinoxaline and a nucleoside

Publications (1)

Publication Number Publication Date
IL111909A0 true IL111909A0 (en) 1995-03-15

Family

ID=6504591

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11190994A IL111909A0 (en) 1993-12-09 1994-12-07 Combination preparations comprising a quinoxaline and a nucleoside

Country Status (12)

Country Link
EP (1) EP0657166B1 (en)
JP (1) JPH07196511A (en)
KR (1) KR950016754A (en)
CN (1) CN1108935A (en)
AT (1) ATE236642T1 (en)
AU (1) AU697486B2 (en)
CA (1) CA2137605A1 (en)
DE (2) DE4342024A1 (en)
HU (1) HU221498B (en)
IL (1) IL111909A0 (en)
NZ (1) NZ270088A (en)
ZA (1) ZA949785B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4437406A1 (en) * 1994-10-19 1996-04-25 Hoechst Ag Quinoxalines, process for their preparation and their use
DE19703131A1 (en) * 1997-01-29 1998-07-30 Bayer Ag Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections
DE19727117A1 (en) * 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkyl derivatives, pharmaceutical compositions containing them and processes for their preparation
AU9318298A (en) * 1997-11-14 1999-06-07 Warner-Lambert Company Small molecule intervention in hiv-1 replication
EP1089979A1 (en) * 1998-06-26 2001-04-11 Du Pont Pharmaceuticals Company Substituted quinoxalin-2(1h)-ones useful as hiv reverse transcriptase inhibitors
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
WO2005018531A2 (en) * 2003-08-26 2005-03-03 'chemical Diversity Research Institute', Ltd. Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
EP1670774A1 (en) * 2003-09-30 2006-06-21 Janssen Pharmaceutica N.V. Quinoxaline compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
ES2955206T3 (en) 2013-07-15 2023-11-29 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell death
EP3217982A1 (en) 2014-11-10 2017-09-20 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
DE102017005091A1 (en) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituted 3,4-dihydropyrido [2,3-b] pyrazine-2 (1H) -one
DE102017005089A1 (en) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituted 3,4-dihydroquinoxaline-2 (1H) -one

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164639T3 (en) * 1991-04-15 2002-03-01 Aventis Pharma Gmbh QUINOXALINAS, PROCEDURE FOR PREPARATION AND EMPLOYMENT.

Also Published As

Publication number Publication date
CN1108935A (en) 1995-09-27
EP0657166A1 (en) 1995-06-14
ZA949785B (en) 1995-07-12
DE59410271D1 (en) 2003-05-15
HUT70037A (en) 1995-09-28
KR950016754A (en) 1995-07-20
AU697486B2 (en) 1998-10-08
NZ270088A (en) 1998-04-27
ATE236642T1 (en) 2003-04-15
AU8042194A (en) 1995-06-15
CA2137605A1 (en) 1995-06-10
HU221498B (en) 2002-10-28
HU9403518D0 (en) 1995-02-28
EP0657166B1 (en) 2003-04-09
DE4342024A1 (en) 1995-06-14
JPH07196511A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
TW207533B (en)
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
ZA949785B (en) Combination preparations comprising a quinoxaline and a nucleoside
ZA928170B (en) Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
DE69426904D1 (en) Phosphonate nucleotide ester derivatives
LTIP1979A (en) New sulphonylaminopyrimidines with therapic activity
GEP20002331B (en) Alkylated Raphamicine Derivatives
ZA925128B (en) Pyrrolidine derivatives,their preparation and medicaments containing them
EP0712853A4 (en) Pyrazole derivative
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
IT1240336B (en) PHARMACEUTICAL, DIETETIC OR VETERINARY COMPOSITIONS FOR EUMETABOLIC ACTIVITIES
TW275615B (en)
GR3017051T3 (en) Azeotropic or azeotropic-like composition of hydrochlorofluoropropane.
EP0522173A4 (en) 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
IL104158A0 (en) Bicyclotridecenone compounds,their preparation and pharmaceutical compositions containing them
MY132057A (en) Quinoxalinones, a process for their preparation and their use
EP0638080A4 (en) 7-DISUBSTITUTED-METHYL-4-OXO-3H -,5H --PYRROLO 3,2-d -]PYRIMIDINE AND PHARMACEUTICAL USES AND COMPOSITIONS CONTAINING THE SAME.
AU4149293A (en) 4-iminoquinolines, processes for their preparation, and their use
ZA881430B (en)
GR3031162T3 (en) Thiazolotriazole and thiazolodiazole derivatives with fungicidal activity.
HU9200916D0 (en) Antimicrobial preparations containing 3,4-dichlor-anilide- and izotiazolone derivatives